MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Spasticity: Treatment"

  • MDS Virtual Congress 2020

    Phenotyping spasticity-associated tonic spasms: implications for therapy

    H. Abboud, S. Saad, M. Elkasaby, C. Kilbane (Cleveland, OH, USA)

    Objective: To evaluate common phenotypes of tonic spasms (TS) in patients with spasticity and inform therapeutic interventions. Background: Spasticity can be associated with several hyperkinetic…
  • MDS Virtual Congress 2020

    Treatment with Botulinum Toxin for Refractory Fever caused by Severe Spasticity

    J. Lester, G. Alvarez-Resendiz, E. Klériga, F. Videgaray, G. Zambito (Huixquilucan, Mexico)

    Objective: Present a series of cases of patients with refractory fever associated to spasticity secondary to a brain or spinal cord injury who developed refractory…
  • MDS Virtual Congress 2020

    Shear wave sonoelastography is effective in detecting myofascial trigger points and spasticity

    R. Bubnov, L. Kalika (Kyiv, Ukraine)

    Objective: The aim was to evaluate effectiveness of shear wave sonoelastography is effective in detecting myofascial trigger points (MTrP) and spasticity. Background: Ultrasound (US) revolutionized…
  • MDS Virtual Congress 2020

    Identification of Factors that Impact Adherence to OnabotulinumtoxinA Treatment for Spasticity in Post-Stroke and Multiple Sclerosis Patients from ASPIRE

    A. Esquenazi, W. Feng, G. Wittenberg, P. Gallien, A. Baricich, K. Fanning, A. Zuzek, G. Francisco, D. Bandari (Elkins Park, PA, USA)

    Objective: Identify baseline clinical characteristics and treatment-related factors that impact adherence to onabotulinumtoxinA (onabotA) treatment in post-stroke and multiple sclerosis (MS) patients from the Adult…
  • MDS Virtual Congress 2020

    Cost-Analysis of the Use of IncobotulinumtoxinA and AbobotulinumtoxinA for the Treatment of Post-Stroke Upper Limb Spasticity Based on Recommended Dosing for Muscles and Clinical Patterns

    M.E Gendron, D. Vézina (Burlington, ON, Canada)

    Objective: To carry out a cost-analysis based on the respective recommended dosing per muscle using IncobotulinumtoxinA (INCO) and AbobotulinumtoxinA (ABO) for the treatment of post-stroke…
  • MDS Virtual Congress 2020

    Perceptions of burden of spasticity and treatment satisfaction among post-stroke patients over the course of a botulinum neurotoxin A (BoNT-A) treatment cycle: An ethnographic study

    J. Jacinto, A. Lysandropoulos, A. Fulford-Smith (Estoril, Portugal)

    Objective: To design an ethnographic study following patients over a botulinum toxin type-A (BoNT-A) treatment cycle to inform individualized treatment. Background: The concept of individualized…
  • MDS Virtual Congress 2020

    Evaluating patient out-of-pocket (OOP) expenses using real world utilization data of botulinum toxins

    L. Turner-Stokes, A. Lysandropoulos, S. Wietek, C. Divers (Harrow, United Kingdom)

    Objective: The objective of this study was to evaluate the impact of different brands of botulinum neurotoxin type A (BoNT-A) on OOP patient spending based…
  • 2019 International Congress

    Guided Self-rehabilitation Contracts combined with simultaneous injections of abobotulinumtoxinA into upper and lower limbs in spastic hemiparesis: baseline data from the ENGAGE study

    J-M. Gracies, G. Francisco, R. Jech, S. Khatkova, C. Rios, P. Maisonobe (Créteil, France)

    Objective: To report baseline data from ENGAGE, an international phase 3b/4, prospective, single-arm, open-label study (NCT02969356) conducted in France, the Czech Republic, Russia and the USA.…
  • 2019 International Congress

    The effect of Guided Self-rehabilitation Contracts combined with simultaneous injections of abobotulinumtoxinA into upper and lower limbs on voluntary movements in adults with spastic hemiparesis

    J-M. Gracies, G. Francisco, R. Jech, S. Khatkova, C. Rios, P. Maisonobe (Créteil, France)

    Objective: To report primary outcomes from ENGAGE, an international phase 3b/4, prospective, single-arm, open-label study (NCT02969356). Background: ENGAGE assessed effects of Guided Self-rehabilitation Contracts (GSC)…
  • 2019 International Congress

    Is teleneurology effective in screening for spasticity?

    K. Harper, B. Eoff, F. Phibbs, D. Isaacs, S. Gallion, E. Thomas, J. Scott, M. Hacker, D. Charles (Nashville, TN, USA)

    Objective: To test the effectiveness of teleneurology for spasticity screening. Background: Spasticity is underdiagnosed and can pose significant problems when not treated. Unfortunately, according to…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley